Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.

Rao, Nanyan

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. [electronic resource] - Chemotherapy 2017 - 246-255 p. digital

Publication Type: Journal Article

1421-9794

10.1159/000470900 doi


Adult
Anthracyclines--therapeutic use
Antigens, Neoplasm--metabolism
Antineoplastic Agents--therapeutic use
Bridged-Ring Compounds--therapeutic use
CD4-Positive T-Lymphocytes--cytology
CD8-Positive T-Lymphocytes--cytology
DNA Topoisomerases, Type II--metabolism
DNA-Binding Proteins--metabolism
Disease-Free Survival
Drug Therapy, Combination
Female
Humans
Ki-67 Antigen--metabolism
Linear Models
Lymphocytes, Tumor-Infiltrating--cytology
Middle Aged
Neoadjuvant Therapy
Remission Induction
Survival Rate
Taxoids--therapeutic use
Triple Negative Breast Neoplasms--drug therapy
Tumor Suppressor Protein p53--metabolism